UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048374
Receipt number R000055134
Scientific Title Evaluation of the effects of test food intakes on the intestinal environment
Date of disclosure of the study information 2022/07/20
Last modified on 2023/06/30 11:02:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the effects of test food intakes on the intestinal environment

Acronym

Evaluation of the effects of test food intakes on the intestinal environment

Scientific Title

Evaluation of the effects of test food intakes on the intestinal environment

Scientific Title:Acronym

Evaluation of the effects of test food intakes on the intestinal environment

Region

Japan


Condition

Condition

Healthy male/female subjects

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of the test food intakes on intestinal environment

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Intestinal metabolites

Key secondary outcomes

Intestinal microbiota
Defecation status (days of defecation, frequency of defecation, volume of defecation, stool consistency, stool color, feeling of residual stool during defecation, abdominal pain during defecation, odor)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Ingesting a whole bag of juice A (200ml) per day within 30 minutes.

Interventions/Control_2

Ingesting a whole bag of juice B (200ml) per day within 30 minutes.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Men and women aged between 20 and 80 at the time of obtaining consent
(2) Persons who have been fully informed about the test, understand its content and are able to give their written consent

Key exclusion criteria

(1) Persons who cannot agree the prohibition of intake of juice made of vegetables and fruits during the study period (from obtaining consent to the end-up of follow-up testing).
(2) Persons who consume foods for specified health uses, functional foods, health foods, yoghurt or probiotic drinks at least three times a week, which may affect the test.
(3) Persons with a history of serious diseases of the heart, liver, kidneys, digestive organs, etc.
(4) Pregnant, lactating or intending to become pregnant during the study period
(5) Persons who has allergies to testing food.
(6) Persons who has present history of the disease.
(7) Persons who are deemed by the study investigator or sub-investigator to be unsuitable to participate in the study

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Shinnosuke
Middle name
Last name Murakami

Organization

Metagen, Inc.

Division name

Headquarters

Zip code

997-0052

Address

246-2 Mizukami, Kakuganji, Tsuruoka, Yamagata, Japan

TEL

+81-235-64-0330

Email

research@metagen.co.jp


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Hattori

Organization

Kakugin Corporation

Division name

Corporate Planning Department

Zip code

997-0034

Address

1-4-23, Hon-Cho, Tsuruoka, Yamagata, Japan

TEL

+81-235-22-2202

Homepage URL


Email

ryo_h@kakugin.com


Sponsor or person

Institute

Metagen, Inc.

Institute

Department

Personal name



Funding Source

Organization

Kakugin Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Daiwa Building, 3-3-10 Nihonbashi-Hongoku-Cho, Chuo-ku, Tokyo

Tel

+81-3-6225-9005

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 07 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 06 Month 20 Day

Date of IRB

2022 Year 06 Month 17 Day

Anticipated trial start date

2022 Year 07 Month 31 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 07 Month 14 Day

Last modified on

2023 Year 06 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055134